Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.16 and traded as high as $0.33. Cell MedX shares last traded at $0.32, with a volume of 3,953 shares.
Cell MedX Stock Performance
The firm has a 50 day moving average price of $0.37 and a two-hundred day moving average price of $0.16.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Stories
- Five stocks we like better than Cell MedX
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MP Materials: Rare Earth Elements Powering the EV Boom
- Trading Stocks: RSI and Why it’s Useful
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
